title: A WWW-accessible knowledge base for the interpretation of hepatitis serologic tests.
abstract: HEPAXPERT is a knowledge-based system that interprets the results of routine serologic tests for infection with hepatitis A and B viruses. The following tests are included: hepatitis A virus anti-bodies (anti-HAV), IgM antibodies to the hepatitis A virus (IgM anti-HAV), hepatitis A virus (HAV in stool, hepatitis B surface antigen (HBsAg) and antibodies (qualitative anti-HBs, quantitative anti-HBs titre), antibodies to hepatitis B core antigen (anti-HBc and IgM anti-HBc), and hepatitis B envelope antigen (HBeAg) and antibodies (anti-HBe). HEPAXPERT/WWW--an implementation of HEPAXPERT-III for WWW--can be reached by URL http://www.swun.com/hepax of the World Wide Web. After selecting HEPAXPERT/WWW, serologic test results can be entered and will be transferred as an e-mail message for subsequent interpretation which is done off-line with HEPAXPERT-III. The textual interpretation is sent back via e-mail. Each qualitative test for hepatitis A and B antibodies and antigens may produce one of four possible results: positive, negative, borderline, and not tested. To cover the resulting 64 (A) and 57344 (B) combinations of findings, the knowledge base of HEPAXPERT/WWW contains 16 rules for hepatitis A and 131 rules for hepatitis B serology interpretation. This basic knowledge is structured such that all possible combinations of findings can be interpreted and there is no overlap in the premises underlying the rules. The reports that the system automatically generates include: (a) the transferred results of the tests; (b) a detailed analysis of the results, including virus exposure, immunity, stage of illness, prognosis, infectiousness, and vaccination recommendation; and (c) optional: an ID to distinguish the origin of the interpretation requests.
authors.affiliation: Department of Medical Computer Sciences, University of Vienna, Austria. ccb@akh-wien.ac.at
authors.forename: C
authors.initials: C
authors.lastname: Chizzali-Bonfadin
authors.forename: K P
authors.initials: KP
authors.lastname: Adlassnig
authors.forename: M
authors.initials: M
authors.lastname: Kreihsl
authors.forename: A
authors.initials: A
authors.lastname: Hatvan
authors.forename: W
authors.initials: W
authors.lastname: Horak
mesh_terms: D001185:Artificial Intelligence; D003195:Computer Communication Networks; D018450:Disease Progression; D004781:Environmental Exposure; D005243:Feces / Q000821:virology; D006506:Hepatitis A / Q000175:diagnosis* / Q000276:immunology; D006508:Hepatitis Antibodies / Q000032:analysis / Q000097:blood*; D006509:Hepatitis B / Q000175:diagnosis* / Q000276:immunology; D006510:Hepatitis B Antibodies / Q000032:analysis / Q000097:blood*; D006512:Hepatitis B Core Antigens / Q000032:analysis / Q000097:blood; D006514:Hepatitis B Surface Antigens / Q000032:analysis / Q000097:blood; D017325:Hepatitis B Vaccines; D006513:Hepatitis B e Antigens / Q000032:analysis / Q000097:blood; D006507:Hepatovirus / Q000276:immunology*; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood; D011379:Prognosis; D012698:Serologic Tests; D014611:Vaccination; D014761:Viral Hepatitis Vaccines; D014774:Virulence
chemical_list: D006508:Hepatitis Antibodies; D006510:Hepatitis B Antibodies; D006512:Hepatitis B Core Antigens; D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines; D006513:Hepatitis B e Antigens; D007075:Immunoglobulin M; D014761:Viral Hepatitis Vaccines